Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D3 Receptor Subtype

The dopamine D3 receptor subtype has been recently targeted as a potential neurochemical modulator of the behavioral actions of psychomotor stimulants, such as cocaine. However, definitive behavioral investigations have been hampered by the lack of highly selective D3 agonists and antagonists. In an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2001-09, Vol.44 (19), p.3175-3186
Hauptverfasser: Robarge, Michael J, Husbands, Stephen M, Kieltyka, Andrzej, Brodbeck, Robbin, Thurkauf, Andrew, Newman, Amy Hauck
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3186
container_issue 19
container_start_page 3175
container_title Journal of medicinal chemistry
container_volume 44
creator Robarge, Michael J
Husbands, Stephen M
Kieltyka, Andrzej
Brodbeck, Robbin
Thurkauf, Andrew
Newman, Amy Hauck
description The dopamine D3 receptor subtype has been recently targeted as a potential neurochemical modulator of the behavioral actions of psychomotor stimulants, such as cocaine. However, definitive behavioral investigations have been hampered by the lack of highly selective D3 agonists and antagonists. In an attempt to design a novel class of D3 ligands with which to study this receptor system, a series of chemically divergent compounds that possessed various structural features that exist within several classes of reputed D3 agents was screened and compared to the recently reported NGB 2904 (58b). On the basis of these results, a novel series of compounds was designed that included functional moieties that were required for high-affinity and selective binding to D3 receptors. All the compounds in this series included an aryl-substituted piperazine ring, a varying alkyl chain linker (C3−C5), and a terminal aryl amide. The compounds were synthesized and evaluated in vitro for binding in CHO cells transfected with human D2, D3, or D4 receptor cDNAs. D3 binding affinities ranged from K i = 1.4 to 1460 nM. The most potent analogue in this series, 51, demonstrated a D3/D2 selectivity of 64 and a D3/D4 selectivity of 1300. Structure−activity relationships for this class of ligands at D3 receptors will provide new leads toward the development of highly selective and potent molecular probes that will prove useful in the elucidation of the role D3 receptors play in the psychomotor stimulant and reinforcing properties of cocaine.
doi_str_mv 10.1021/jm010146o
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71150536</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71150536</sourcerecordid><originalsourceid>FETCH-LOGICAL-a220t-5d69fc26a671f2bc29dec8ea6396b8193585846d374fd6803dc61ce5a2b32133</originalsourceid><addsrcrecordid>eNpFkVtv1DAQhS0EokvhgT-A_AICCYMviZN9RF3KRctF7D6BkOU4k663jh3spGr4IfxeXLq0TzOj8-mMdA5Cjxl9xShnr_c9ZZQVMtxBC1ZySoqaFnfRglLOCZdcHKEHKe0ppYJxcR8dMVYWQtbVAv1ZQbJnHmvf4s3sx10-Ew4d_vGcvxRkZc3OhRiGHfjZvRjsAFH_tp4wMruf2p3PrnNTiFeq0bEJl7q3LSSsE_4cLsDhtT3L3glvwIEZ7QXgLkSc_-BVGDLs8yLwNzAwjFnYTM04D_AQ3eu0S_DoMI_R9vTt9uQ9WX959-HkzZpozulIylYuO8OllhXreGP4sgVTg5ZiKZuaLUVZl3UhW1EVXStrKlojmYFS80ZwJsQxenZtO8Twa4I0qt4mA85pD2FKqspB0VLIDD45gFPTQ6uGaHsdZ_U_yAw8PQA6Ge26qL2x6ZYrqKTsnxG55mwa4fJG1_FcyUpUpdp-3ajTgm7Fp-Kj-n7rq01S-zBFn-NQjKqr4tVN8eIvW56dlA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71150536</pqid></control><display><type>article</type><title>Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D3 Receptor Subtype</title><source>MEDLINE</source><source>ACS Publications</source><creator>Robarge, Michael J ; Husbands, Stephen M ; Kieltyka, Andrzej ; Brodbeck, Robbin ; Thurkauf, Andrew ; Newman, Amy Hauck</creator><creatorcontrib>Robarge, Michael J ; Husbands, Stephen M ; Kieltyka, Andrzej ; Brodbeck, Robbin ; Thurkauf, Andrew ; Newman, Amy Hauck</creatorcontrib><description>The dopamine D3 receptor subtype has been recently targeted as a potential neurochemical modulator of the behavioral actions of psychomotor stimulants, such as cocaine. However, definitive behavioral investigations have been hampered by the lack of highly selective D3 agonists and antagonists. In an attempt to design a novel class of D3 ligands with which to study this receptor system, a series of chemically divergent compounds that possessed various structural features that exist within several classes of reputed D3 agents was screened and compared to the recently reported NGB 2904 (58b). On the basis of these results, a novel series of compounds was designed that included functional moieties that were required for high-affinity and selective binding to D3 receptors. All the compounds in this series included an aryl-substituted piperazine ring, a varying alkyl chain linker (C3−C5), and a terminal aryl amide. The compounds were synthesized and evaluated in vitro for binding in CHO cells transfected with human D2, D3, or D4 receptor cDNAs. D3 binding affinities ranged from K i = 1.4 to 1460 nM. The most potent analogue in this series, 51, demonstrated a D3/D2 selectivity of 64 and a D3/D4 selectivity of 1300. Structure−activity relationships for this class of ligands at D3 receptors will provide new leads toward the development of highly selective and potent molecular probes that will prove useful in the elucidation of the role D3 receptors play in the psychomotor stimulant and reinforcing properties of cocaine.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm010146o</identifier><identifier>PMID: 11543687</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Amides - chemical synthesis ; Amides - chemistry ; Amides - metabolism ; Animals ; Binding, Competitive ; Biological and medical sciences ; Catecholaminergic system ; CHO Cells ; Combinatorial Chemistry Techniques ; Cricetinae ; Drug Design ; Fluorenes - chemical synthesis ; Fluorenes - chemistry ; Fluorenes - metabolism ; Humans ; Ligands ; Medical sciences ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Pharmacology. Drug treatments ; Piperazines - chemical synthesis ; Piperazines - chemistry ; Piperazines - metabolism ; Radioligand Assay ; Receptors, Dopamine D2 - metabolism ; Receptors, Dopamine D3 ; Receptors, Dopamine D4 ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2001-09, Vol.44 (19), p.3175-3186</ispartof><rights>Copyright © 2001 American Chemical Society</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm010146o$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm010146o$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>315,782,786,27083,27931,27932,56745,56795</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14060136$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11543687$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Robarge, Michael J</creatorcontrib><creatorcontrib>Husbands, Stephen M</creatorcontrib><creatorcontrib>Kieltyka, Andrzej</creatorcontrib><creatorcontrib>Brodbeck, Robbin</creatorcontrib><creatorcontrib>Thurkauf, Andrew</creatorcontrib><creatorcontrib>Newman, Amy Hauck</creatorcontrib><title>Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D3 Receptor Subtype</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The dopamine D3 receptor subtype has been recently targeted as a potential neurochemical modulator of the behavioral actions of psychomotor stimulants, such as cocaine. However, definitive behavioral investigations have been hampered by the lack of highly selective D3 agonists and antagonists. In an attempt to design a novel class of D3 ligands with which to study this receptor system, a series of chemically divergent compounds that possessed various structural features that exist within several classes of reputed D3 agents was screened and compared to the recently reported NGB 2904 (58b). On the basis of these results, a novel series of compounds was designed that included functional moieties that were required for high-affinity and selective binding to D3 receptors. All the compounds in this series included an aryl-substituted piperazine ring, a varying alkyl chain linker (C3−C5), and a terminal aryl amide. The compounds were synthesized and evaluated in vitro for binding in CHO cells transfected with human D2, D3, or D4 receptor cDNAs. D3 binding affinities ranged from K i = 1.4 to 1460 nM. The most potent analogue in this series, 51, demonstrated a D3/D2 selectivity of 64 and a D3/D4 selectivity of 1300. Structure−activity relationships for this class of ligands at D3 receptors will provide new leads toward the development of highly selective and potent molecular probes that will prove useful in the elucidation of the role D3 receptors play in the psychomotor stimulant and reinforcing properties of cocaine.</description><subject>Amides - chemical synthesis</subject><subject>Amides - chemistry</subject><subject>Amides - metabolism</subject><subject>Animals</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Catecholaminergic system</subject><subject>CHO Cells</subject><subject>Combinatorial Chemistry Techniques</subject><subject>Cricetinae</subject><subject>Drug Design</subject><subject>Fluorenes - chemical synthesis</subject><subject>Fluorenes - chemistry</subject><subject>Fluorenes - metabolism</subject><subject>Humans</subject><subject>Ligands</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperazines - chemical synthesis</subject><subject>Piperazines - chemistry</subject><subject>Piperazines - metabolism</subject><subject>Radioligand Assay</subject><subject>Receptors, Dopamine D2 - metabolism</subject><subject>Receptors, Dopamine D3</subject><subject>Receptors, Dopamine D4</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkVtv1DAQhS0EokvhgT-A_AICCYMviZN9RF3KRctF7D6BkOU4k663jh3spGr4IfxeXLq0TzOj8-mMdA5Cjxl9xShnr_c9ZZQVMtxBC1ZySoqaFnfRglLOCZdcHKEHKe0ppYJxcR8dMVYWQtbVAv1ZQbJnHmvf4s3sx10-Ew4d_vGcvxRkZc3OhRiGHfjZvRjsAFH_tp4wMruf2p3PrnNTiFeq0bEJl7q3LSSsE_4cLsDhtT3L3glvwIEZ7QXgLkSc_-BVGDLs8yLwNzAwjFnYTM04D_AQ3eu0S_DoMI_R9vTt9uQ9WX959-HkzZpozulIylYuO8OllhXreGP4sgVTg5ZiKZuaLUVZl3UhW1EVXStrKlojmYFS80ZwJsQxenZtO8Twa4I0qt4mA85pD2FKqspB0VLIDD45gFPTQ6uGaHsdZ_U_yAw8PQA6Ge26qL2x6ZYrqKTsnxG55mwa4fJG1_FcyUpUpdp-3ajTgm7Fp-Kj-n7rq01S-zBFn-NQjKqr4tVN8eIvW56dlA</recordid><startdate>20010913</startdate><enddate>20010913</enddate><creator>Robarge, Michael J</creator><creator>Husbands, Stephen M</creator><creator>Kieltyka, Andrzej</creator><creator>Brodbeck, Robbin</creator><creator>Thurkauf, Andrew</creator><creator>Newman, Amy Hauck</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20010913</creationdate><title>Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D3 Receptor Subtype</title><author>Robarge, Michael J ; Husbands, Stephen M ; Kieltyka, Andrzej ; Brodbeck, Robbin ; Thurkauf, Andrew ; Newman, Amy Hauck</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a220t-5d69fc26a671f2bc29dec8ea6396b8193585846d374fd6803dc61ce5a2b32133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amides - chemical synthesis</topic><topic>Amides - chemistry</topic><topic>Amides - metabolism</topic><topic>Animals</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Catecholaminergic system</topic><topic>CHO Cells</topic><topic>Combinatorial Chemistry Techniques</topic><topic>Cricetinae</topic><topic>Drug Design</topic><topic>Fluorenes - chemical synthesis</topic><topic>Fluorenes - chemistry</topic><topic>Fluorenes - metabolism</topic><topic>Humans</topic><topic>Ligands</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperazines - chemical synthesis</topic><topic>Piperazines - chemistry</topic><topic>Piperazines - metabolism</topic><topic>Radioligand Assay</topic><topic>Receptors, Dopamine D2 - metabolism</topic><topic>Receptors, Dopamine D3</topic><topic>Receptors, Dopamine D4</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Robarge, Michael J</creatorcontrib><creatorcontrib>Husbands, Stephen M</creatorcontrib><creatorcontrib>Kieltyka, Andrzej</creatorcontrib><creatorcontrib>Brodbeck, Robbin</creatorcontrib><creatorcontrib>Thurkauf, Andrew</creatorcontrib><creatorcontrib>Newman, Amy Hauck</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Robarge, Michael J</au><au>Husbands, Stephen M</au><au>Kieltyka, Andrzej</au><au>Brodbeck, Robbin</au><au>Thurkauf, Andrew</au><au>Newman, Amy Hauck</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D3 Receptor Subtype</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2001-09-13</date><risdate>2001</risdate><volume>44</volume><issue>19</issue><spage>3175</spage><epage>3186</epage><pages>3175-3186</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>The dopamine D3 receptor subtype has been recently targeted as a potential neurochemical modulator of the behavioral actions of psychomotor stimulants, such as cocaine. However, definitive behavioral investigations have been hampered by the lack of highly selective D3 agonists and antagonists. In an attempt to design a novel class of D3 ligands with which to study this receptor system, a series of chemically divergent compounds that possessed various structural features that exist within several classes of reputed D3 agents was screened and compared to the recently reported NGB 2904 (58b). On the basis of these results, a novel series of compounds was designed that included functional moieties that were required for high-affinity and selective binding to D3 receptors. All the compounds in this series included an aryl-substituted piperazine ring, a varying alkyl chain linker (C3−C5), and a terminal aryl amide. The compounds were synthesized and evaluated in vitro for binding in CHO cells transfected with human D2, D3, or D4 receptor cDNAs. D3 binding affinities ranged from K i = 1.4 to 1460 nM. The most potent analogue in this series, 51, demonstrated a D3/D2 selectivity of 64 and a D3/D4 selectivity of 1300. Structure−activity relationships for this class of ligands at D3 receptors will provide new leads toward the development of highly selective and potent molecular probes that will prove useful in the elucidation of the role D3 receptors play in the psychomotor stimulant and reinforcing properties of cocaine.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>11543687</pmid><doi>10.1021/jm010146o</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2001-09, Vol.44 (19), p.3175-3186
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_71150536
source MEDLINE; ACS Publications
subjects Amides - chemical synthesis
Amides - chemistry
Amides - metabolism
Animals
Binding, Competitive
Biological and medical sciences
Catecholaminergic system
CHO Cells
Combinatorial Chemistry Techniques
Cricetinae
Drug Design
Fluorenes - chemical synthesis
Fluorenes - chemistry
Fluorenes - metabolism
Humans
Ligands
Medical sciences
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Pharmacology. Drug treatments
Piperazines - chemical synthesis
Piperazines - chemistry
Piperazines - metabolism
Radioligand Assay
Receptors, Dopamine D2 - metabolism
Receptors, Dopamine D3
Receptors, Dopamine D4
Structure-Activity Relationship
title Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D3 Receptor Subtype
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T17%3A17%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20and%20Synthesis%20of%20%5B(2,3-Dichlorophenyl)piperazin-1-yl%5Dalkylfluorenylcarboxamides%20as%20Novel%20Ligands%20Selective%20for%20the%20Dopamine%20D3%20Receptor%20Subtype&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Robarge,%20Michael%20J&rft.date=2001-09-13&rft.volume=44&rft.issue=19&rft.spage=3175&rft.epage=3186&rft.pages=3175-3186&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm010146o&rft_dat=%3Cproquest_pubme%3E71150536%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71150536&rft_id=info:pmid/11543687&rfr_iscdi=true